Literature DB >> 8085259

Molecular genetic studies of HLA class II alleles in sarcoidosis.

M Ishihara1, S Ohno, T Ishida, H Ando, T Naruse, Y Nose, H Inoko.   

Abstract

Previous HLA serological studies showed positive associations of the DR52 antigen, the DR52-associated antigens (DR3, DR5 and DR6) and the DR8 antigen with sarcoidosis. To investigate the HLA alleles that may contribute to the genetic susceptibility to sarcoidosis at the DNA level, HLA-DRB1, -DRB3, -DQA1 and DQB1 genotyping using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed in 63 Japanese patients with sarcoidosis. The frequencies of the DR52-associated DRB1 alleles (DRB1*11, DRB1*12 and DRB1*14 except DRB1*1302), DRB1*08, DRB3*0101, DQA1*0501 and DQB1*0301 were significantly increased in patients compared with healthy controls. The significant increase of DRB3*0101, DQA1*0501 and DQB1*0301 could be explained by linkage disequilibrium with the DR52-associated DRB1 alleles. It must be noted that the DR8 haplotype, which does not possess the DRB3 gene, also showed a significant increase in sarcoidosis. These results suggest that the HLA-alleles responsible for the susceptibility to sarcoidosis are located at the HLA-DRB1 locus rather than the HLA-DRB3, -DQA1 and -DQB1 loci. In contrast, DRB1*1302 may confer resistance to the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085259     DOI: 10.1111/j.1399-0039.1994.tb02331.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  15 in total

Review 1.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 2.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

Review 3.  Mycobacteria and sarcoidosis.

Authors:  O M Kon; R M du Bois
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

4.  A case study of sibling relationship in sarcoidosis by HLA-DNA genotyping.

Authors:  M Ishihara; T Ishida; N Mizuki; H Inoko; H Ando; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

Review 5.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 6.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

7.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

8.  Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome.

Authors:  Annegret Fischer; Ruta Valentonyte; Almut Nebel; Michael Nothnagel; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  J Mol Med (Berl)       Date:  2008-03-01       Impact factor: 4.599

9.  Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLP.

Authors:  M Ishihara; T Ishida; N Mizuki; H Inoko; H Ando; S Ohno
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

10.  Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan.

Authors:  Yuri Asukata; Masao Ota; Akira Meguro; Yoshihiko Katsuyama; Mami Ishihara; Kenichi Namba; Nobuyoshi Kitaichi; Shin-Ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Hidetoshi Inoko; Shigeaki Ohno; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.